JY
PHGE.WS

Jeff Yass’s BiomX Inc. Warrants to purchase one-half of a share of Common Stock PHGE.WS Stock Holding History

Jeff Yass’s Portfolio PHGE.WS Stock Details PHGE.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-68,024
Closed -$9K – 14370
2022
Q1 		$9K Buy
+68,024
New +$8.04K ﹤0.01% 12768

Other funds holding PHGE.WS

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Jeff Yass's PHGE.WS Position: Q2 2022 in Review

Jeff Yass sold out of BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) in Q2 2022, closing a stake of 68,024 shares — an estimated $9K sold.

Jeff Yass first reported a position in PHGE.WS in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 8 funds tracked by Wall St. Rank hold PHGE.WS as of Q2 2022.

  • Jeff Yass reported no remaining BiomX Inc. Warrants to purchase one-half of a share of Common Stock position as of Q2 2022 after selling out during the quarter.
  • Jeff Yass sold 68,024 BiomX Inc. Warrants to purchase one-half of a share of Common Stock shares in Q2 2022, an estimated $9K.
  • Jeff Yass first reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in Q1 2022 and held it in 1 quarter.
  • Jeff Yass's BiomX Inc. Warrants to purchase one-half of a share of Common Stock position peaked at $9K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held BiomX Inc. Warrants to purchase one-half of a share of Common Stock as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.